|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Loxo_Oncology
gptkb:Im_Clone_Systems
gptkb:Avid_Radiopharmaceuticals
|
|
gptkbp:awards
|
Best Places to Work
Innovation Award
Fortune 500 Company
Corporate Responsibility Award
Top Employer in the U. S.
|
|
gptkbp:clinical_trial
|
Phase 1 trials for Alzheimer's drugs
Phase 2 trials for autoimmune diseases
Phase 2 trials for cancer drugs
Phase 3 trials for depression drugs
Phase 3 trials for diabetes drugs
|
|
gptkbp:employees
|
Approximately 35,000
|
|
gptkbp:founded
|
1876
|
|
gptkbp:founder
|
gptkb:Eli_Lilly
|
|
gptkbp:headquarters
|
gptkb:Indianapolis,_Indiana
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lilly USA, LLC
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:operates_in
|
gptkb:United_States
|
|
gptkbp:parent_company
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:partnerships
|
gptkb:Astra_Zeneca
gptkb:Boehringer_Ingelheim
gptkb:Eisai_Co.,_Ltd.
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
|
|
gptkbp:philanthropy
|
gptkb:Lilly_Foundation
gptkb:Lilly_Endowment_Inc.
Lilly Diabetes Challenge
Lilly Global Health Initiative
|
|
gptkbp:products
|
gptkb:diabetes
Antidepressants
Cancer medications
|
|
gptkbp:research_focus
|
gptkb:diabetes
gptkb:Cardiovascular_diseases
gptkb:Oncology
Immunology
Neuroscience
|
|
gptkbp:subsidiary
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:sustainability_initiatives
|
gptkb:Community_engagement
Diversity and inclusion
Environmental stewardship
Employee well-being
Access to medicines
|
|
gptkbp:website
|
www.lilly.com
|
|
gptkbp:bfsParent
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:bfsLayer
|
5
|